CNTNAP1 and chronic inflammatory demyelinating polyradiculoneuropathy: About 10 years ago, the pathogenic role of the antibodies anti-CNTN1, anti-Caspr1, and NF-155 was associated with 5–10% of CIDP patients [86,87].